{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:01:39Z","timestamp":1792512099575,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["ZZ13-YQ-027"],"award-info":[{"award-number":["ZZ13-YQ-027"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010097","name":"China Association for Science and Technology","doi-asserted-by":"publisher","award":["2017QNRC001"],"award-info":[{"award-number":["2017QNRC001"]}],"id":[{"id":"10.13039\/100010097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82105037"],"award-info":[{"award-number":["82105037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.eclinm.2022.101457","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T19:38:01Z","timestamp":1653075481000},"page":"101457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Oral pharmacological treatments for chronic prostatitis\/chronic pelvic pain syndrome: A systematic review and network meta-analysis of randomised controlled trials"],"prefix":"10.1016","volume":"48","author":[{"given":"Zongshi","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6990-6175","authenticated-orcid":false,"given":"Jianbo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey S.W.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7978-7325","authenticated-orcid":false,"given":"Ran","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.Christopher","family":"Doiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Curtis","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eclinm.2022.101457_bib0001","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101457_bib0002","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0022-5347(05)65301-3","article-title":"Prevalence and correlates of prostatitis in the health professionals follow-up study cohort","volume":"167","author":"Collins","year":"2002","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0003","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-5347(05)68562-X","article-title":"The National Institutes Of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic prostatitis collaborative research network","volume":"162","author":"Litwin","year":"1999","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101457_bib0004","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0022-5347(05)66541-X","article-title":"Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index","volume":"165","author":"Nickel","year":"2001","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101457_bib0005","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/S0022-5347(05)64170-5","article-title":"Prevalence of prostatitis-like symptoms in a community based cohort of older men","volume":"168","author":"Roberts","year":"2002","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0006","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.eururo.2015.08.061","article-title":"Contemporary management of chronic prostatitis\/chronic pelvic pain syndrome","volume":"69","author":"Magistro","year":"2016","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101457_bib0007","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/14656561003709748","article-title":"Pharmacotherapy strategies in chronic prostatitis\/chronic pelvic pain syndrome management","volume":"11","author":"Murphy","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0008","first-page":"63","article-title":"Management of men diagnosed with chronic prostatitis\/chronic pelvic pain syndrome who have failed traditional management","volume":"9","author":"Curtis Nickel","year":"2007","journal-title":"Rev Urol"},{"issue":"25","key":"10.1016\/j.eclinm.2022.101457_bib0009","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1056\/NEJMoa0803240","article-title":"Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome","volume":"359","author":"Nickel","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101457_bib0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-141-8-200410190-00005","article-title":"Ciprofloxacin or tamsulosin in men with chronic prostatitis\/chronic pelvic pain syndrome: a randomized, double-blind trial","volume":"141","author":"Alexander","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2022.101457_bib0011","article-title":"Pharmacological interventions for treating chronic prostatitis\/chronic pelvic pain syndrome","volume":"10","author":"Franco","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0012","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"issue":"7","key":"10.1016\/j.eclinm.2022.101457_bib0013","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1464-410X.2012.11088.x","article-title":"alpha-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis\/chronic pelvic pain syndrome","volume":"110","author":"Thakkinstian","year":"2012","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101457_bib0014","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.2010.1913","article-title":"Management of chronic prostatitis\/chronic pelvic pain syndrome: a systematic review and network meta-analysis","volume":"305","author":"Anothaisintawee","year":"2011","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.eclinm.2022.101457_bib0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2022.101457_bib0016","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2022.101457_bib0017","article-title":"Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101457_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017392","article-title":"Comparative efficacy and acceptability of antiepileptic drugs for classical trigeminal neuralgia: a Bayesian network meta-analysis protocol","volume":"8","author":"Qin","year":"2018","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.eclinm.2022.101457_bib0019","doi-asserted-by":"crossref","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11136-005-1317-1","article-title":"Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)","volume":"15","author":"Propert","year":"2006","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2022.101457_bib0022","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jclinepi.2015.10.010","article-title":"Questionable assumptions hampered interpretation of a network meta-analysis of primary care depression treatments","volume":"71","author":"Linde","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101457_bib0023","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jrsm.1195","article-title":"GetReal in network meta-analysis: a review of the methodology","volume":"7","author":"Efthimiou","year":"2016","journal-title":"Res Synth Methods"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101457_bib0024","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.juro.2011.05.071","article-title":"Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study","volume":"186","author":"Nickel","year":"2011","journal-title":"J Urol"},{"issue":"13","key":"10.1016\/j.eclinm.2022.101457_bib0025","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101457_bib0026","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-141-8-200410190-00005","article-title":"Ciprofloxacin or tamsulosin in men with chronic prostatitis\/chronic pelvic pain syndrome: a randomized, double-blind trial","volume":"141","author":"Alexander","year":"2004","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5534\/wjmh.2017.35.2.120","article-title":"The clinical efficacy of pollen extract and vitamins on chronic prostatitis\/chronic pelvic pain syndrome is linked to a decrease in the pro-inflammatory cytokine interleukin-8","volume":"35","author":"Cai","year":"2017","journal-title":"World J Mens Health"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101457_bib0028","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3892\/etm.2014.1861","article-title":"Pollen extract in association with vitamins provides early pain relief in patients affected by chronic prostatitis\/chronic pelvic pain syndrome","volume":"8","author":"Cai","year":"2014","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0029","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0022-5347(05)63960-2","article-title":"Terazosin therapy for chronic prostatitis\/chronic pelvic pain syndrome: a randomized, placebo controlled trial","volume":"169","author":"Cheah","year":"2003","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101457_bib0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00345-010-0537-3","article-title":"Effects of a 6-month course of tamsulosin for chronic prostatitis\/chronic pelvic pain syndrome: a multicenter, randomized trial","volume":"29","author":"Chen","year":"2011","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0031","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.urology.2013.09.024","article-title":"The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis\/chronic pelvic pain syndrome","volume":"83","author":"Giannantoni","year":"2014","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101457_bib0032","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.ju.0000101487.83730.80","article-title":"A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis\/chronic pelvic pain syndrome","volume":"171","author":"Kaplan","year":"2004","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101457_bib0033","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5213\/inj.2011.15.3.172","article-title":"Efficacy of anticholinergics for chronic prostatitis\/chronic pelvic pain syndrome in young and middle-aged patients: a single-blinded, prospective, multi-center study","volume":"15","author":"Kim","year":"2011","journal-title":"Int Neurourol J"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0034","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5213\/inj.2011.15.2.92","article-title":"Tamsulosin monotherapy versus combination therapy with antibiotics or anti-inflammatory agents in the treatment of chronic pelvic pain syndrome","volume":"15","author":"Kim","year":"2011","journal-title":"Int Neurourol J"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/1871523018666181128164252","article-title":"Flower pollen extract in association with vitamins (Deprox 500(R)) versus serenoa repens in chronic prostatitis\/chronic pelvic pain syndrome: a comparative analysis of two different treatments","volume":"18","author":"Macchione","year":"2019","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101457_bib0036","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4081\/aiua.2018.4.260","article-title":"The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: a prospective non blinded study utilizing flower pollen extracts versus bioflavonoids","volume":"90","author":"Maurizi","year":"2019","journal-title":"Arch Ital Urol Androl"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101457_bib0037","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000302716","article-title":"Treatment of chronic prostatitis\/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study","volume":"84","author":"Morgia","year":"2010","journal-title":"Urol Int"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101457_bib0038","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0090-4295(03)00583-1","article-title":"Levofloxacin for chronic prostatitis\/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial","volume":"62","author":"Nickel","year":"2003","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.eclinm.2022.101457_bib0039","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1464-410X.2003.04766.x","article-title":"A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)","volume":"93","author":"Nickel","year":"2004","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101457_bib0040","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/01.ju.0000159198.83103.01","article-title":"Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study","volume":"173","author":"Nickel","year":"2005","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101457_bib0041","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.juro.2011.03.028","article-title":"Silodosin for men with chronic prostatitis\/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study","volume":"186","author":"Nickel","year":"2011","journal-title":"J Urol"},{"issue":"17","key":"10.1016\/j.eclinm.2022.101457_bib0042","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/archinternmed.2010.319","article-title":"Pregabalin for the treatment of men with chronic prostatitis\/chronic pelvic pain syndrome: a randomized controlled trial","volume":"170","author":"Pontari","year":"2010","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101457_bib0043","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0090-4295(99)00358-1","article-title":"Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial","volume":"54","author":"Shoskes","year":"1999","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101457_bib0044","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.eururo.2006.09.036","article-title":"A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS)","volume":"51","author":"Tugcu","year":"2007","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101457_bib0045","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2009.05.046","article-title":"A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study","volume":"56","author":"Wagenlehner","year":"2009","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0046","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/147323000803600205","article-title":"Tamsulosin treatment of chronic non-bacterial prostatitis","volume":"36","author":"Ye","year":"2008","journal-title":"J Int Med Res"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101457_bib0047","doi-asserted-by":"crossref","first-page":"e13319","DOI":"10.1111\/and.13319","article-title":"Beneficial effect of tamsulosin combined with dapoxetine in management of type III prostatitis with premature ejaculation","volume":"51","author":"Zhao","year":"2019","journal-title":"Andrologia"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101457_bib0048","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1590\/S0100-879X2009005000021","article-title":"Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA)","volume":"42","author":"Zhao","year":"2009","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101457_bib0049","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.urology.2005.05.001","article-title":"Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: a systematic review of efficacy and adverse effects","volume":"66","author":"MacDonald","year":"2005","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.eclinm.2022.101457_bib0050","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1464-410X.2004.05154.x","article-title":"Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects","volume":"94","author":"MacDonald","year":"2004","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101457_bib0051","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1464-4096.2001.02537.x-i1","article-title":"Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects","volume":"89","author":"Wilt","year":"2002","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101457_bib0052","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(05)65407-9","article-title":"Tamsulosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects","volume":"167","author":"Wilt","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eclinm.2022.101457_bib0053","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. ISBN 978-94-92671-16-5. If a publisher and\/or location is required, include: EAU Guidelines Office, Arnhem, The Netherlands. http:\/\/uroweb.org\/guidelines\/compilations-of-all-guidelines\/."},{"issue":"3","key":"10.1016\/j.eclinm.2022.101457_bib0054","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1258\/0956462053420239","article-title":"Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study","volume":"16","author":"Goldmeier","year":"2005","journal-title":"Int J STD AIDS"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101457_bib0055","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.urology.2012.07.035","article-title":"Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis\/chronic pelvic pain syndrome","volume":"80","author":"Nickel","year":"2012","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101457_bib0056","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1590\/S1677-55382006000200008","article-title":"Effect of allopurinol in chronic nonbacterial prostatitis: a double blind randomized clinical trial","volume":"32","author":"Ziaee","year":"2006","journal-title":"Int Braz J Urol"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101457_bib0057","doi-asserted-by":"crossref","first-page":"e41941","DOI":"10.1371\/journal.pone.0041941","article-title":"Therapeutic intervention for chronic prostatitis\/chronic pelvic pain syndrome (CP\/CPPS): a systematic review and meta-analysis","volume":"7","author":"Cohen","year":"2012","journal-title":"PLoS One"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022001870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022001870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:13:24Z","timestamp":1762888404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537022001870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":57,"alternative-id":["S2589537022001870"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101457","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral pharmacological treatments for chronic prostatitis\/chronic pelvic pain syndrome: A systematic review and network meta-analysis of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101457"}}